MedTrace Logo

Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality

NCT06624826 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-03

No results posted yet for this study

Summary

Comparison of the visual performance of a refractive extended depth of focus intraocular lens in an emmetropic or monovision modality

Conditions

  • Cataract

Interventions

DEVICE

Emmetropic modality

PureSee IOL, emmetropic modality

DEVICE

Monovision modality

PureSee IOL, monovision modality

Sponsors & Collaborators

  • Prim. Prof. Dr. Oliver Findl, MBA

    lead OTHER

Principal Investigators

  • Oliver Findl, Prim. Prof. Dr. · Vienna Institute for Research in Ocular Surgery (VIROS)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-10-01
Completion
2026-09-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06624826 on ClinicalTrials.gov